Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ENGN
ENGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ENGN News
Biotech Sector Sees FDA Approvals and Layoffs
1d ago
NASDAQ.COM
enGene Reports Wider Q2 Loss Amid Clinical Updates
4d ago
NASDAQ.COM
enGene Holdings Reports Strong Q2 Earnings and Financial Position
5d ago
seekingalpha
Pomerantz Investigates enGene for Securities Fraud Claims
Jun 04 2026
PRnewswire
Pomerantz LLP Investigates Securities Fraud Claims Against enGene Therapeutics
Jun 02 2026
Globenewswire
Pomerantz LLP Investigates Securities Fraud Claims Against enGene Therapeutics
May 26 2026
Globenewswire
Investigation into enGene Therapeutics Investor Claims
May 07 2026
Globenewswire
enGene Reports Interim Results from NMIBC Clinical Trial
May 07 2026
Yahoo Finance
Global Oncology Market Set for Rapid Growth
Mar 19 2026
PRnewswire
Global Oncology Market Expected to Reach $748.17 Billion
Mar 19 2026
Newsfilter
ENGENE HOLDINGS INC.: OPPENHEIMER LOWERS TARGET PRICE FROM $33 TO $30
Mar 11 2026
moomoo
enGene Holdings Q1 Financial Highlights
Mar 09 2026
seekingalpha
enGene Holdings to Participate in Multiple Investor Conferences
Feb 20 2026
Yahoo Finance
EnGene Files Shelf Registration for Up to $40 Million
Feb 20 2026
Yahoo Finance
enGene Holdings Inc. (ENGN) Expands $125M Debt Facility, Stock Rises 14%
Jan 23 2026
seekingalpha
enGene Holdings Secures $125 Million Loan Agreement with Hercules Capital
Jan 20 2026
Businesswire
Show More News
